# Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study

> **NCT01763398** · — · COMPLETED · sponsor: **Yonsei University** · enrollment: 500 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01763398
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2016-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01763398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01763398, "Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01763398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*